Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

✍ Scribed by Bernard Escudier; Anna Pluzanska; Piotr Koralewski; Alain Ravaud; Sergio Bracarda; Cezary Szczylik; Christine Chevreau; Marek Filipek; Bohuslav Melichar; Emilio Bajetta; Vera Gorbunova; Jacques-Olivier Bay; Istvan Bodrogi; Agnieszka Jagiello-Gruszfeld; Nicola Moore

• Book ID: 117302270
• Publisher: The Lancet
• Year: 2007
• Tongue: English
• Weight: 178 KB
• Volume: 370
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(07)61904-7